4-(3-甲酰基丙基)苯甲腈 | 101478-66-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(3-甲酰基丙基)苯甲腈
• 英文名称: 4-(4-oxobutyl)benzonitrile
• 英文别名: 4-(p-Cyanophenyl)butyraldehyde
• CAS: 101478-66-4
• 化学式: C₁₁H₁₁NO
• 分子量: 173.214
• InChiKey: KXQGRCMHTJUCJB-UHFFFAOYSA-N

物化性质

• 沸点：
  327.1±35.0 °C(Predicted)
• 密度：
  1.06±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(3-甲酰基丙基)苯甲腈 、 (R)-N1-(5-chloro-2-(5-chloropyridin-2-yl)-6-methylpyrimidin-4-yl)-2-phenylethane-1,2-diamine 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 反应 1.0h， 生成 4-(4-((R)-2-(5-chloro-2-(5-chloropyridin-2-yl)pyrimidin-4-ylamino)-1-phenylethylamino)butyl)benzonitrile
  参考文献：
  名称：

  Pyridinylpyrimidines selectively inhibit human methionine aminopeptidase-1

  摘要：

  Cellular protein synthesis is initiated with methionine in eukaryotes with few exceptions. Methionine aminopeptidases (MetAPs) which catalyze the process of N-terminal methionine excision are essential for all organisms. In mammals, type 2 MetAP (MetAP2) is known to be important for angiogenesis, while type 1 MetAP (MetAP1) has been shown to play a pivotal role in cell proliferation. Our previous high-throughput screening of a commercial compound library uncovered a novel class of inhibitors for both human MetAP1 (HsMetAP1) and human MetAP2 (HsMetAP2). This class of inhibitors contains a pyridinylpyrimidine core. To understand the structure-activity relationship (SAR) and to search for analogues of 2 with greater potency and higher HsMetAP1-selectivity, a total of 58 analogues were acquired through either commercial source or by in-house synthesis and their inhibitory activities against HsMetAP1 and HsMetAP2 were determined. Through this systematic medicinal chemistry analysis, we have identified (1) 5-chloro-6-methyl-2-pyridin-2-ylpyrimidine as the minimum element for the inhibition of HsMetAP1; (2) 5'-chloro as the favored substituent on the pyridine ring for the enhanced potency against HsMetAP1; and (3) long C4 side chains as the essentials for higher HsMetAP1-selectivity. At the end of our SAR campaign, 25b, 25c, 26d and 30a-30c are among the most selective and potent inhibitors of purified HsMetAP1 reported to date. In addition, we also performed crystallographic analysis of one representative inhibitor (26d) in complex with N-terminally truncated HsMetAP1. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.02.023
• 作为产物：
  描述：

  4-[3-(1,3-dioxolan-2-yl)prop-1-yl]benzonitrile 在 盐酸 作用下， 以 四氢呋喃 为溶剂， 生成 4-(3-甲酰基丙基)苯甲腈
  参考文献：
  名称：

  Novel liquid crystal mixtures

  摘要：

  含有以下式化合物的液晶混合物##STR1##其中n代表数字0或1；X.sup.1和X.sup.2表示单共价键或X.sup.1和X.sup.2中的一个符号也表示--COO--，--OOC--或--CH.sub.2 CH.sub.2--；环A.sup.1，A.sup.2和A.sup.3代表1,4-苯撑基，2-氟-1,4-苯撑基或反-1,4-环己撑基，或其中一个环也代表2,5-二取代嘧啶环或反-2,5-二取代间二氧杂环己烷环；R.sup.1表示4-烯基或在环己基环上也是2Z-烯基；R.sup.2表示烷基，烷氧基，--CN或--NCS，还描述了这些化合物的制备以及用于电光目的。

  公开号：

  US04709030A1

文献信息

• Liquid crystals
  申请人：Hoffmann La Roche Inc.

  公开号：US05238602A1

  公开（公告）日：1993-08-24

  Compounds of the formula ##STR1## wherein n stands for the number 0 or 1; the rings A.sup.1, A.sup.2 and A.sup.3 represent 1,4-phenylene, 2-fluoro-1,4-phenylene or trans-1,4-cyclohexylene or one of these rings also represents a 2,5-disubstituted pyrimidine ring or a trans-2,5-disubstituted m-dioxane ring; X.sup.1 represents a single covalent bond, --COO--, --OOC--, --CH.sub.2 CH.sub.2 --, p--C.sub.6 H.sub.4 --, --CH.sub.2 CH.sub.2 --p-- C.sub.6 H.sub.4 --, --CH.sub.2 CH.sub.2 --p--C.sub.6 H.sub.4 --CH.sub.2 CH.sub.2 -- or, insofar as the rings A.sup.1 and A.sup.2 represent 1,4-phenylene, also --NON--; R.sup.2 represents 1E-alkenyl, 2Z-alkenyl, 3E-alkenyl, 4-alkenyl or alkenyloxy, with the proviso that the oxygen atom in alkenyloxy is linked with a saturated carbon atom; and R.sup.1 signifies 1E-alkenyl, 2Z-alkenyl, 3E-alkenyl, 4-alkenyl or, insofar as R.sup.2 represents alkenyloxy, also alkyl, their manufacture, as well as liquid crystalline mixtures and the use for electro-optical purposes.

  公式##STR1##的化合物，其中n代表数字0或1；环A.sup.1、A.sup.2和A.sup.3代表1,4-苯基、2-氟-1,4-苯基或反式-1,4-环己基，其中一个环还代表2,5-二取代嘧啶环或反式-2,5-二取代间二氧杂环；X.sup.1代表单一共价键，--COO--, --OOC--, --CH.sub.2 CH.sub.2 --, p--C.sub.6 H.sub.4 --, --CH.sub.2 CH.sub.2 --p-- C.sub.6 H.sub.4 --, --CH.sub.2 CH.sub.2 --p--C.sub.6 H.sub.4 --CH.sub.2 CH.sub.2 --，或者，只要环A.sup.1和A.sup.2代表1,4-苯基，也代表--NON--; R.sup.2代表1E-烯基、2Z-烯基、3E-烯基、4-烯基或烯基氧基，条件是烯基氧基中的氧原子与饱和碳原子相连；R.sup.1表示1E-烯基、2Z-烯基、3E-烯基、4-烯基，或者，只要R.sup.2代表烯基氧基，也代表烷基，它们的制造，以及液晶混合物及其用于电光用途。
• 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
  申请人：Kim Dae-Kee

  公开号：US20050261299A1

  公开（公告）日：2005-11-24

  Compounds of the formula: wherein R1, R2, R3, A1 and A2 are as defined herein, which are used advantageously in inhibiting the TGF-β and/or activin signaling pathway in mammals.

  该化合物的公式为：其中R1、R2、R3、A1和A2的定义如本文所述，这些化合物在哺乳动物中有效地抑制TGF-β和/或activin信号通路。
• [EN] 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS ALK5 AND/OR ALK4 INHIBITORS<br/>[FR] IMIDAZOLES SUBSTITUES PAR 2-PYRIDYLE, UTILISES COMME INHIBITEURS D'ALK5 ET/OU D'ALK4
  申请人：IN2GEN CO LTD

  公开号：WO2005103028A1

  公开（公告）日：2005-11-03

  This invention relates to 2-pyridyl substituted imidazoles which are inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors.

  本发明涉及2-吡啶基取代咪唑，其为转化生长因子-β（TGF-β）类型I受体（ALK5）和/或活化素类型I受体（ALK4）的抑制剂，其制备方法以及它们在医学上的使用，特别是在治疗和预防由这些受体介导的疾病状态中的使用。
• Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1<i>H</i>-imidazoles as ALK5 inhibitors
  作者：Myoung-Soon Park、Hyun-Ju Park、Young Jae An、Joon Hun Choi、Geunyoung Cha、Hwa Jeong Lee、So-Jung Park、Purushottam M. Dewang、Dae-Kee Kim

  DOI：10.1080/14756366.2020.1734799

  日期：2020.1.1

  has been synthesised and evaluated for their ALK5 inhibitory activity in an enzyme assay and in a cell-based luciferase reporter assay. Incorporation of a quinoxalin-6-yl moiety and a methylene linker at the 4- and 2-position of the imidazole ring, respectively, and a m-CONH2 substituent in the phenyl ring generated a highly potent and selective ALK5 inhibitor 11e. Docking model of ALK5 in complex with

  摘要 合成了一系列2,4-二取代的5-（6-烷基吡啶-2-基）-1 H-咪唑类化合物7a–c，11a–h和16a–h，并在一定条件下评估了它们对ALK5的抑制活性。酶分析和基于细胞的萤光素酶报告基因分析。分别在咪唑环的4-位和2-位引入喹喔啉-6-基部分和亚甲基接头，以及在苯环中引入m- CONH 2取代基，产生了高效的选择性ALK5抑制剂11e。与11e形成复合物的ALK5的对接模型表明，它与ATP结合袋非常吻合，相互作用良好。
• Carbonylative Transformation of Allylarenes with CO Surrogates: Tunable Synthesis of 4-Arylbutanoic Acids, 2-Arylbutanoic Acids, and 4-Arylbutanals
  作者：Fu-Peng Wu、Da Li、Jin-Bao Peng、Xiao-Feng Wu

  DOI：10.1021/acs.orglett.9b02047

  日期：2019.7.19

  In this Communication, procedures for the selective synthesis of 4-arylbutanoic acids, 2-arylbutanoic acids, and 4-arylbutanals from the same allylbenzenes have been developed. With formic acid or TFBen as the CO surrogate, reactions proceed selectively and effectively under carbon monoxide gas-free conditions.